Taiwan Biomaterial Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 09, 2022
Share
Taiwan Biomaterial Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 24.03 million compared to TWD 11 million a year ago. Net income was TWD 3.28 million compared to net loss of TWD 12.89 million a year ago. Basic earnings per share from continuing operations was TWD 0.08 compared to basic loss per share from continuing operations of TWD 0.39 a year ago. Diluted earnings per share from continuing operations was TWD 0.08 compared to diluted loss per share from continuing operations of TWD 0.39 a year ago.
For the six months, sales was TWD 40.4 million compared to TWD 15.16 million a year ago. Net loss was TWD 1.29 million compared to TWD 25.97 million a year ago. Basic loss per share from continuing operations was TWD 0.03 compared to TWD 0.79 a year ago. Diluted loss per share from continuing operations was TWD 0.03 compared to TWD 0.79 a year ago.
Taiwan Biomaterial Co., Ltd. is a Taiwan-based company mainly engaged in provision of medical equipment. The products are still in research and development stage. The Company's subsidiary TAIWAN MEDICAL RAPID PROTOTYPING CO., LTD.(TRP) is engaged in trial production of medical equipment. Main products include foam artificial meninges products, stroke thrombus aspiration catheter products, repair and regeneration products for early degenerative arthritis and others.